Title variants
Languages of publication
Abstracts
Current status of innovative drug industry is briefly presented with emphasis on new biopharmaceuticals introduced in the years 1995-2007. Adverse effects and problems of safety and effectiveness of these pharmacotherapeutics are reviewed. A separate part of the manuscript is devoted to the newly introduced methods of molecular diagnostics based on pharmacogenomics and employed in personalized medicine. Theranostic approach consisting in a joint use of drugs and companion diagnostics are characterized.
Discipline
Journal
Year
Issue
Pages
33-49
Physical description
Contributors
author
author
References
Document Type
MONOGRAPHY
Publication order reference
Roman Kaliszan, Katedra Biofarmacji i Farmakodynamiki, Akademia Medyczna, ul. Gen. J. Hallera 107, Gdansk, Poland
Identifiers
YADDA identifier
bwmeta1.element.element-from-psjc-d3761ee9-f2b9-38e7-bcc0-08466b8c25b7